Cargando…
Development of MTL-CEBPA: Small Activating RNA Drug for Hepatocellular Carcinoma
BACKGROUND: Oligonucleotide drug development has revolutionised the drug discovery field. Within this field, ‘small’ or ‘short’ activating RNAs (saRNA) are a more recently discovered category of short double-stranded RNA with clinical potential. saRNAs promote transcription from target loci, a pheno...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Bentham Science Publishers
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6204661/ https://www.ncbi.nlm.nih.gov/pubmed/29886828 http://dx.doi.org/10.2174/1389201019666180611093428 |